86 related articles for article (PubMed ID: 17708355)
1. Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potential.
Vairaktaris E; Goutzanis L; Kalokerinos G; Yannopoulos A; Yapijakis C; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris AC; Tesseromatis C; Patsouris E
In Vivo; 2007; 21(4):615-21. PubMed ID: 17708355
[TBL] [Abstract][Full Text] [Related]
2. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Spyridonidou S; Vassiliou S; Derka S; Nkenke E; Yapijakis C; Vylliotis A; Lazaris A; Patsouris E
Anticancer Res; 2007; 27(3B):1465-73. PubMed ID: 17595763
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and oral oncogenesis.
Vairaktaris E; Spyridonidou S; Goutzanis L; Vylliotis A; Lazaris A; Donta I; Perrea D; Yapijakis C; Patsouris E
Anticancer Res; 2007; 27(6B):4185-93. PubMed ID: 18225590
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis.
Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Patsouris E
In Vivo; 2007; 21(5):745-50. PubMed ID: 18019407
[TBL] [Abstract][Full Text] [Related]
5. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
6. Diabetes enhances cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Yapijakis C; Derka S; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris A; Patsouris E
Int J Oral Maxillofac Surg; 2008 Jan; 37(1):60-5. PubMed ID: 17825529
[TBL] [Abstract][Full Text] [Related]
7. Diabetes does not influence oral oncogenesis through fibroblast growth factor receptors.
Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Strantzias P; Kalimeras E; Patsouris E
In Vivo; 2007; 21(4):623-8. PubMed ID: 17708356
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathway.
Vairaktaris E; Goutzanis L; Kalokerinos G; Vassiliou S; Spyridonidou S; Avgoustidis D; Strantzias P; Lazaris A; Papageorgiou G; Ragos V; Yapijakis C; Patsouris E
J Craniomaxillofac Surg; 2007 Dec; 35(8):382-7. PubMed ID: 18023197
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation and apoptosis culminate in early stages of oral oncogenesis.
Derka S; Vairaktaris E; Papakosta V; Vassiliou S; Acil Y; Vylliotis A; Spyridonidou S; Lazaris AC; Mourouzis C; Kokkori A; Moulavasili P; Perrea D; Donta I; Yapijakis C; Patsouris E
Oral Oncol; 2006 May; 42(5):540-50. PubMed ID: 16464633
[TBL] [Abstract][Full Text] [Related]
10. Diabetes enhances the expression of H-ras and suppresses the expression of EGFR leading to increased cell proliferation.
Vairaktaris E; Goutzanis L; Yapijakis C; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris AC; Strantzias P; Patsouris E
Histol Histopathol; 2009 May; 24(5):531-9. PubMed ID: 19283661
[TBL] [Abstract][Full Text] [Related]
11. EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis.
Vairaktaris E; Loukeri S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Papakosta V; Lazaris A; Agrogiannis G; Yapijakis C; Perrea D; Patsouris E
In Vivo; 2007; 21(5):791-6. PubMed ID: 18019413
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.
Vairaktaris E; Goutzanis L; Vassiliou S; Spyridonidou S; Nkenke E; Papageorgiou G; Strantzias P; Lazaris A; Yapijakis C; Patsouris E
J Cancer Res Clin Oncol; 2008 Mar; 134(3):337-44. PubMed ID: 17704947
[TBL] [Abstract][Full Text] [Related]
13. H-ras and c-fos exhibit similar expression patterns during most stages of oral oncogenesis.
Vairaktaris E; Papakosta V; Derka S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Lazaris A; Kokkori A; Moulavassili P; Loukeri S; Perrea D; Donta I; Yapijakis C; Patsouris E
In Vivo; 2008; 22(5):621-8. PubMed ID: 18853758
[TBL] [Abstract][Full Text] [Related]
14. Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis.
Vairaktaris E; Moulavassili P; Loukeri S; Spyridonidou S; Yapijakis C; Vassiliou S; Nkenke E; Vylliotis A; Papakosta V; Lazaris A; Patsouris E
J Musculoskelet Neuronal Interact; 2007; 7(2):185-90. PubMed ID: 17627089
[TBL] [Abstract][Full Text] [Related]
15. Tissue expression of gelsolin in oral carcinogenesis progression and its clinicopathological implications.
Shieh DB; Chen IW; Wei TY; Shao CY; Chang HJ; Chung CH; Wong TY; Jin YT
Oral Oncol; 2006 Jul; 42(6):599-606. PubMed ID: 16753328
[TBL] [Abstract][Full Text] [Related]
16. Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway.
Goutzanis L; Vairaktaris E; Yapijakis C; Kavantzas N; Nkenke E; Derka S; Vassiliou S; Acil Y; Kessler P; Stavrianeas N; Perrea D; Donta I; Skandalakis P; Patsouris E
Oral Oncol; 2007 Feb; 43(2):165-73. PubMed ID: 16860589
[TBL] [Abstract][Full Text] [Related]
17. Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis.
Vairaktaris E; Papageorgiou G; Derka S; Moulavassili P; Nkenke E; Kessler P; Vassiliou S; Papakosta V; Spyridonidou S; Vylliotis A; Lazaris AC; Anagnostopoulou S; Mourouzis C; Yapijakis C; Patsouris E
J Cancer Res Clin Oncol; 2007 Apr; 133(4):227-33. PubMed ID: 17072648
[TBL] [Abstract][Full Text] [Related]
18. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
Vairaktaris E; Yapijakis C; Psyrri A; Spyridonidou S; Yannopoulos A; Lazaris A; Vassiliou S; Ferekidis E; Vylliotis A; Nkenke E; Patsouris E
Anticancer Res; 2007; 27(2):979-84. PubMed ID: 17465230
[TBL] [Abstract][Full Text] [Related]
19. The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
Papakosta V; Vairaktaris E; Vylliotis A; Derka S; Nkenke E; Vassiliou S; Lazaris A; Mourouzis C; Rallis G; Spyridonidou S; Anagnostopoulou S; Perrea D; Donta I; Yapijakis C; Patsouris E
Anticancer Res; 2006; 26(4B):2957-62. PubMed ID: 16886620
[TBL] [Abstract][Full Text] [Related]
20. Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation.
Wu HT; Ko SY; Fong JH; Chang KW; Liu TY; Kao SY
J Oral Pathol Med; 2009 Feb; 38(2):206-13. PubMed ID: 18331557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
